Annexon’s Director Keeps Buying as Shares Dip: 8,000 Shares Added Amid Volatile Market and Mixed Insider Sentiment
Insider Carson William H. keeps buying Annexon shares amid volatility—signaling long‑term confidence in its biotech pipeline and future value.
3 minutes to read

